Novartis AG
Processes and intermediates for NEP inhibitor synthesis

Last updated:

Abstract:

The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril, inter alia via nitro 5 compounds. It further relates to new intermediate compounds and their use for said new chemical synthesis route, as well as a new catalyst ligand.

Status:
Grant
Type:

Utility

Filling date:

16 Aug 2017

Issue date:

1 Dec 2020